Altered lncRNA GAS5 expression in patients with rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis and inflammatory bowel disease has been described, both up-regulation and down-regulation mechanisms have been highlighted, these mechanisms directly affect the GCR that are involved in this type of pathology 8. Here, GAS5 is linked to systemic lupus erythematosus.